Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Bausch Lomb Corporation made materially false and/or misleading statements and/or failed to disclose that: Bausch & Lomb announced a voluntary recall of intraocular lenses on its enVista platform on March 27, 2025, due to reports of toxic anterior segment syndrome (TASS), a potential complication in cataract surgery. The recall may raise short-term concerns about product safety and regulatory scrutiny. Following this news, Bausch & Lomb's stock price fell over 10% on that same day.
In order to be eligible to join the BLCO class action lawsuit, you must have incurred a loss on shares of Bausch Lomb Corporation purchased during the class period listed above.
TOP
